Sherritt MA - Search Results

1

Use of recombinant vaccinia to restimulate antigen specific human peripheral blood cytotoxic T lymphocytes.

Gardner J, Khanna R, Sherritt MA, Suhrbier A. Gardner J, et al. Among authors: sherritt ma. J Virol Methods. 1997 Apr;65(1):105-9. doi: 10.1016/s0166-0934(96)02173-8. J Virol Methods. 1997. PMID: 9128867

2

Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines.

Sherritt MA, Gardner J, Elliott SL, Schmidt C, Purdie D, Deliyannis G, Heath WR, Suhrbier A. Sherritt MA, et al. Eur J Immunol. 2000 Feb;30(2):671-7. doi: 10.1002/1521-4141(200002)30:2<671::AID-IMMU671>3.0.CO;2-H. Eur J Immunol. 2000. PMID: 10671225 Free article.

3

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

Duraiswamy J, Sherritt M, Thomson S, Tellam J, Cooper L, Connolly G, Bharadwaj M, Khanna R. Duraiswamy J, et al. Blood. 2003 Apr 15;101(8):3150-6. doi: 10.1182/blood-2002-10-3092. Epub 2002 Dec 5. Blood. 2003. PMID: 12468425 Free article.

4

EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: potential use of gp350/gp85 CTL epitopes for vaccine design.

Khanna R, Sherritt M, Burrows SR. Khanna R, et al. J Immunol. 1999 Mar 1;162(5):3063-9. J Immunol. 1999. PMID: 10072559

5

Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.

Moss DJ, Khanna R, Sherritt M, Elliott SL, Burrows SR. Moss DJ, et al. J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S80-3. J Acquir Immune Defic Syndr. 1999. PMID: 10430223 Review.

6

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

Khanna R, Bell S, Sherritt M, Galbraith A, Burrows SR, Rafter L, Clarke B, Slaughter R, Falk MC, Douglass J, Williams T, Elliott SL, Moss DJ. Khanna R, et al. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10391-6. doi: 10.1073/pnas.96.18.10391. Proc Natl Acad Sci U S A. 1999. PMID: 10468618 Free PMC article.

7

Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.

Sherritt M, Cooper L, Moss DJ, Kienzle N, Altman J, Khanna R. Sherritt M, et al. Int Immunol. 2001 Mar;13(3):265-71. doi: 10.1093/intimm/13.3.265. Int Immunol. 2001. PMID: 11222495

8

Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design.

Bharadwaj M, Sherritt M, Khanna R, Moss DJ. Bharadwaj M, et al. Vaccine. 2001 Jun 14;19(27):3769-77. doi: 10.1016/s0264-410x(01)00085-8. Vaccine. 2001. PMID: 11395212

9

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.

Tellam J, Sherritt M, Thomson S, Tellam R, Moss DJ, Burrows SR, Wiertz E, Khanna R. Tellam J, et al. J Biol Chem. 2001 Sep 7;276(36):33353-60. doi: 10.1074/jbc.M104535200. Epub 2001 Jul 2. J Biol Chem. 2001. PMID: 11435434 Free article.

10

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

Thomson SA, Elliott SL, Sherritt MA, Sproat KW, Coupar BE, Scalzo AA, Forbes CA, Ladhams AM, Mo XY, Tripp RA, Doherty PC, Moss DJ, Suhrbier A. Thomson SA, et al. Among authors: sherritt ma. J Immunol. 1996 Jul 15;157(2):822-6. J Immunol. 1996. PMID: 8752934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters